Reports

PRIORITY PRESS - Digestive Disease Week (DDW 2014)

New Biologic Therapies in the Treatment of Ulcerative Colitis

Chicago, Illinois / May 3-6, 2014

Chicago - New biologic treatments for ulcerative colitis (UC) are being developed to offer advantages to patients with respect to administration route, dosing regimen and side effect profile; in addition, agents with different mechanisms of...

PRIORITY PRESS - 16th International Congress on Infectious Diseases

Adult Vaccination: Time for a Paradigm Shift from Infants to Adults

Cape Town, South Africa / April 2-5, 2014

Cape Town - A great deal of attention has been focused on pediatric immunization over the years. As a result, society has witnessed resounding success in controlling vaccine-preventable diseases (VPDs) in the young. Success has been less...

PRIORITY PRESS - 7th World Congress of the World Institute of Pain (WIP 2014)

Pain Management: New Approaches in Opioid-Induced Constipation

Maastricht, The Netherlands / May 7-10, 2014

Maastricht - As the population ages, the incidence of chronic pain and resulting use of opioids for treatment is increasing. While opioids provide significant analgesic effect, their benefit is accompanied by common side effects. In an...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 49th Annual Meeting of the European Association for the Study of the Liver (EASL)

New Direct-acting Antiviral Agents in the Treatment of Hepatitis C Genotype 1 Infection

London, UK / April 9-13, 2014

Guest Editor: Jordan J. Feld, MD, MPHToronto Centre for Liver DiseaseToronto Western HospitalFrancis Family Liver ClinicUniversity Health NetworkMcLauglin-Rotman Centre for Global HealthToronto,...

PRIORITY PRESS - Digestive Disease Week (DDW 2014)

Optimizing Therapy with Biologic Agents in Inflammatory Bowel Disease

Chicago, Illinois / May 3-6, 2014

Chicago - Oral and poster presentations at DDW 2014 reflected the changes that have evolved in the approach to treatment of inflammatory bowel disease as new data have been accumulated on the use of the tumor necrosis factor alpha (TNF)...

PRIORITY PRESS - 2014 Genitourinary Cancers Symposium

Cardiovascular Risk with ADT for Advanced Prostate Cancer

San Francisco, California / January 30-February 1, 2014

San Francisco - The principal goal of androgen deprivation therapy (ADT) is to reduce testosterone to castrate levels, thereby depriving prostate cancer cells of their key growth substrate. However, several studies have shown that ADT...

PRIORITY PRESS - 23rd Annual Canadian Conference on HIV/AIDS Research (CAHR)

Global Gains in the HIV Epidemic: Intensified and Simplified Treatment Regimens

St. John’s, Newfoundland and Labrador / May 1-4, 2014

St. John’s - Since the mid 90s, there has been a virtual explosion of novel antiretroviral therapies (ART) targeting HIV replication along multiple pathways. This has led to the development of potent new combinations of ARTs that are...

MEDI-NEWS - Based on Guidelines Prepared by the Meningococcal B Pilot Project Task Group

Young Infants and the Multi-Component Serogroup B Vaccine: New NACI Recommendations for Healthcare Professionals

March 26, 2014

Invasive meningococcal disease (IMD) is an acute and serious infection caused by the bacterium Neisseria meningitidis. In Canada, 5 serogroups are responsible for IMD, of which serogroup B is now the most prevalent, especially among infants...

PRIORITY PRESS - 7th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

New Treatment Strategies for Prophylaxis in Severe Hemophilia: Moving from Clinical Trials into Real World Practice

Brussels, Belgium / February 26-28, 2014

Brussels - The focus of care in hemophilia A and B has shifted from the management of acute bleeding episodes (on-demand therapy) toward prophylaxis to prevent bleeding episodes and disease sequelae. Currently, hemophilia A patients...